Gynecomastia and premature - Thelarche: A guide for practitioners

Pediatrics in Review

Volumn 28, Issue 9, 2007, Pages

  Diamantopoulos, Stavros ^b   Bao, Yong ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANASTROZOLE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTIULCER AGENT; CARDIOVASCULAR AGENT; CIMETIDINE; CLOMIFENE CITRATE; CYCLOSPORIN; CYPROTERONE; DIURETIC AGENT; ETHIONAMIDE; FINASTERIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; ISONIAZID; KETOCONAZOLE; LETROZOLE; METHOTREXATE; METRONIDAZOLE; PENICILLAMINE; PROTON PUMP INHIBITOR; RALOXIFENE; SEX HORMONE; TAMOXIFEN; TESTOLACTONE; THEOPHYLLINE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ADRENAL TUMOR; ANAMNESIS; BREAST DEVELOPMENT; BREAST DISEASE; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; GYNECOMASTIA; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPOGONADISM; INCIDENCE; LABORATORY TEST; LIVER TUMOR; PATIENT REFERRAL; PEDIATRICIAN; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRECOCIOUS PUBERTY; REVIEW; SYSTEMIC DISEASE; TESTIS TUMOR; TREATMENT OUTCOME;

BREAST; CHILD; FEMALE; GYNECOMASTIA; HUMANS; MALE; PUBERTY, PRECOCIOUS;

EID: 34548669116     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.28-9-e57     Document Type: Review

References (12)

1. Mahoney CP. Adolescent gynecomastia. Differential diagnosis and management. Pediatr Clin North Am. 1990;37:1389-1404
2. Berkovitz GD, Guerami A, Brown TR, MacDonald PC, Migeon CJ. Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids. J Clin Invest. 1985;75:1763-1769
3. Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr. 2004;145:71-76
4. Plourde PV, Reiter EO, Jou HC, et al. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:4428-4433
5. Stanhope R, Brook CC. Thelarche variant: a new syndrome of precocious sexual maturation? Acta Endocrinol (Copenh). 1990;123:481-486
6. Van Winter JT, Noller KL, Zimmerman D. Natural history of premature thelarche in Olmsted County, Minnesota, 1940 to 1984. J Pediatr. 1990;116:278-280
7. Saenz de Rodriguez CA, Bongiovanni AM, Conde de Borrego L. An epidemic of precocious development in Puerto Rican children. J Pediatr. 1985;107:393-396
8. Nizzoli G, Del Corno G, Fara GM, Chiumello G. Gynaecomastia and premature thelarche in a schoolchildren population of northern Italy. Acta Endocrinol Suppl (Copenh). 1986;279:227-231
9. Tiwary CM, Ward JA. Use of hair products containing hormone or placenta by US military personnel. J Pediatr Endocrinol Metab. 2003;16:1025-1032
10. Herman-Giddens ME, Slora EJ, Wasserman RC. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatr Res in Office Settings network. Pediatrics. 1997;99:505-512
11. Pasquino AM, Pucarelli I, Passeri F. Progression of premature thelarche to central precocious puberty. J Pediatr. 1995;126:11-14
12. Salardi S, Cacciari E, Mainetti B, Mazzanti L, Pirazzoli P. Outcome of premature thelarche: relation to puberty and final height. Arch Dis Child. 1998;79:173-174